More on ABEO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-60.0% Growth)
- Ratings (7.5 Score)
- Holders

Upcoming Events

- Earnings (11/16/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Abeona Therapeutics (NQ:ABEO)
Delayed: 5.95 -0.03 (0.5%)
Prev. Close $5.98  
Open$5.98 
52 Wk High$9.44 
52 Wk Low$2.05 
Day High$6.10 
Day Low$5.93 
P/E N/A  
EPS$0.00 
Volume195,947 


Sep 2, 2026 07:30 AM Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
Sep 1, 2026 07:30 AM Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 14, 2026 04:32 PM Form SCHEDULE 13G/A ABEONA THERAPEUTICS INC. Filed by: MONTANOVA CAPITAL, LLC
Aug 14, 2026 08:33 AM Abeona Therapeutics (ABEO) PT Lowered to $21 at Oppenheimer
Aug 13, 2026 07:31 AM Form 10-Q ABEONA THERAPEUTICS INC. For: Jun 30
Aug 13, 2026 07:30 AM Form 8-K ABEONA THERAPEUTICS INC. For: Aug 13
Aug 13, 2026 07:30 AM Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update
Aug 6, 2026 07:30 AM Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026
Aug 4, 2026 07:31 AM CMS grants NTAP status for Abeona's ZEVASKYN skin therapy
Aug 4, 2026 07:30 AM CMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN®
View All Articles

Entities mentioned with ABEO

View All Entities